EMAP-II facilitates TNF-R1 apoptotic signalling in endothelial cells and induces TRADD mobilization

[1]  A. Eggermont,et al.  Intratumoural expression of TNF‐R1 and EMAP‐II in relation to response of patients treated with TNF‐based isolated limb perfusion , 2006, International Journal of Cancer.

[2]  S. Corbett,et al.  Endothelial-monocyte activating polypeptide II alters fibronectin based endothelial cell adhesion and matrix assembly via alpha5 beta1 integrin. , 2005, Experimental cell research.

[3]  A. Minden,et al.  PAK4 Functions in Tumor Necrosis Factor (TNF) α-induced Survival Pathways by Facilitating TRADD Binding to the TNF Receptor* , 2005, Journal of Biological Chemistry.

[4]  S. Libutti,et al.  Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells. , 2005, Cytokine.

[5]  Sun-Young Chang,et al.  Heparan Sulfate Regulates the Antiangiogenic Activity of Endothelial Monocyte-Activating Polypeptide-II at Acidic pH , 2005, Molecular Pharmacology.

[6]  D. Kabelitz,et al.  Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. , 2004, Immunity.

[7]  P. Symonds,et al.  Endothelial monocyte‐activating polypeptide‐II (EMAP‐II): a novel inducer of lymphocyte apoptosis , 2004, Journal of leukocyte biology.

[8]  P. Symonds,et al.  Colorectal Cancer Cells Induce Lymphocyte Apoptosis by an Endothelial Monocyte-Activating Polypeptide-II-Dependent Mechanism 1 , 2004, The Journal of Immunology.

[9]  J. Tschopp,et al.  Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.

[10]  G. Cohen,et al.  Fas-associated Death Domain Protein and Caspase-8 Are Not Recruited to the Tumor Necrosis Factor Receptor 1 Signaling Complex during Tumor Necrosis Factor-induced Apoptosis* , 2003, Journal of Biological Chemistry.

[11]  A. Eggermont,et al.  Current uses of isolated limb perfusion in the clinic and a model system for new strategies. , 2003, The Lancet. Oncology.

[12]  S. Libutti,et al.  Improved antitumor response to isolated limb perfusion with tumor necrosis factor after upregulation of endothelial monocyte-activating polypeptide II in soft tissue sarcoma. , 2002 .

[13]  M. Karin,et al.  Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.

[14]  S. Libutti,et al.  Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II). , 2000, Cytokine.

[15]  E. Kohn,et al.  Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis. , 2000, Microvascular research.

[16]  D. Männel,et al.  Tumor necrosis factor induces tumor necrosis via tumor necrosis factor receptor type 1-expressing endothelial cells of the tumor vasculature. , 2000, The American journal of pathology.

[17]  S. Libutti,et al.  Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus. , 1999, Cancer research.

[18]  Jun Li,et al.  Endothelial-Monocyte Activating Polypeptide Ii, a Novel Antitumor Cytokine That Suppresses Primary and Metastatic Tumor Growth and Induces Apoptosis in Growing Endothelial Cells , 1999, The Journal of experimental medicine.

[19]  S. Jones,et al.  TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1. , 1999, Journal of immunology.

[20]  S. Libutti,et al.  In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-alpha is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII). , 1999, Cancer research.

[21]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[22]  A. Eggermont,et al.  Rationale for using TNFα and chemotherapy in regional therapy of melanoma , 1994 .

[23]  P. Familletti,et al.  Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. , 1992, The Journal of biological chemistry.

[24]  L. Tartaglia,et al.  Two TNF receptors. , 1992, Immunology today.

[25]  J. Denekamp,et al.  Selective induction of endothelial cell tissue factor in the presence of a tumour‐derived mediator: A potential mechanism of flavone acetic acid action in tumour vasculature , 1991, International journal of cancer.